✦ LIBER ✦

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)

✍ Scribed by Shinji Atagi; Masaaki Kawahara; Akira Yokoyama; Hiroaki Okamoto; Nobuyuki Yamamoto; Yuichiro Ohe; Toshiyuki Sawa; Satoshi Ishikura; Taro Shibata; Haruhiko Fukuda; Nagahiro Saijo; Tomohide Tamura

Book ID: 117786055
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 216 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70139-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4001 ORAL Standard Thoracic Radiotherapy

4001 ORAL Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatin in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer – a Phase III Trial of the Japan Clinical Oncology Group (JCOG0301)

✍ Atagi, S.; Kawahara, M.; Yokoyama, A.; Okamoto, H.; Yamamoto, N.; Ohe, Y.; Ishik 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

O-155 Randomized phase III trial of carb

O-155 Randomized phase III trial of carboplatin (Cb) or cisplatin (P) in combination with etoposide (E) in elderly or poor-risk patients with extensive disease small cell lung cancer (ED-SCLC): Report of a Japan Clinical Oncology Group Trial (JCOG9702)

✍ Kunitoh, H.; Okamoto, H.; Watanabe, K.; Kunikane, H.; Yokoyama, A.; Kudoh, S.; I 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

O-095 A phase III trial of docetaxel/car

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)

✍ Lorigan, P. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Randomized Phase III Trial of Platinum-D

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)

✍ Takeda, K.; Hida, T.; Sato, T.; Ando, M.; Seto, T.; Satouchi, M.; Ichinose, Y.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

A phase II trial of individualized respo

A phase II trial of individualized response-based induction chemotherapy (IC) of mitomycin-C, vindesine, cisplatin (MVP) followed by thoracic radiotherapy (TRT) with daily low-dose carboplatin (CBDCA) for the treatment of unresectable stage III non-small-cell lung cancer (NSCLC)

✍ Shinbo, T; Makino, M; Tsukada, H; Yokoyama, A; Saitou, M; Kurita, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 230 KB